Le Registre des lobbyistes
| Objets | Détails | Catégories |
|---|---|---|
|
Développement économique, Commerce international
|
ACCESS & BENEFIT SHARING: TRIPS AGREEMENT in respect of protecting intellectual property and preventing increased uncertainty
|
Politique ou Programme
|
|
Agriculture
|
ADVENTITIOUS PRESCENCE POLICY in respect of new agricultural biotechnology products
|
Politique ou Programme
|
|
Environnement
|
BIOSAFETY PROTOCOL in respect of Canada's participation in global discussions to ensure an enabling environment for safe new technologies
|
Politique ou Programme
|
|
Environnement, Santé, Industrie
|
CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS in respect of modern, science-based regulations to reflect rapidly changing new technologies
|
Règlement, Proposition législative, Projet de loi ou résolution
|
|
Impôts et finances
|
Clarify the administration of SR&ED program to ensure clinical trials and international research conducted in Canada qualifies as eligible expenses
|
Politique ou Programme
|
|
Propriété intellectuelle
|
Creation of a modern policy environment that recognizes international standards and reviews, and establishes clarity on data ownership for intellectual property
|
Politique ou Programme
|
|
Santé, Industrie
|
Establish accountability with the federally established Canadian Drug Agency (formerly Canadian Agency for Drugs and Technologies and Health) (CADTH) and its Common Drug Review process (Health Canada)
|
Politique ou Programme
|
|
Agriculture, Santé, Industrie, Commerce international
|
FOOD AND DRUGS ACT AND REGULATIONS in respect of streamlining regulatory burden and ensuring appropriate climate for the introduction of new technologies
|
Règlement, Proposition législative, Projet de loi ou résolution
|
|
Agriculture, Questions touchant les consommateurs, Santé, Industrie
|
FOOD LABELLING in respect of mitigating the unnecessary introduction of new labelling requirements for products already approved under current regulated process and in respect of maintaining harmonization of requirements with trading nations
|
Politique ou Programme
|
|
Budget, Développement économique, Industrie, Recherche et développement, Impôts et finances
|
IMPROVEMENTS TO THE Scientifc Research & Experimental Development TAX CREDITS
|
Politique ou Programme
|
|
Propriété intellectuelle, Commerce international
|
INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS in respect of creating Canada as one of the world's most competitive jurisdictions in protecting IP (e.g., match level of European Union via CETA negotiations)
|
Politique ou Programme, Règlement
|
|
Agriculture, Santé, Industrie
|
NOVEL FOODS in respect of maintaining a science-based regulatory system for novel foods derived from plant and animal biotechnology
|
Politique ou Programme
|
|
Développement économique, Santé, Industrie, Recherche et développement
|
ORPHAN PRODUCTS to establish formal regulations, policies or programs to encourage the research, development and introduction of new technologies to treat "orphan" or neglected diseases
|
Règlement, Politique ou Programme
|
|
Santé, Industrie, Commerce intérieur, Recherche et développement
|
PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW to ensure new guidelines and directives do not create disincentives for the introduction of new treatments in Canada
|
Politique ou Programme
|
|
Agriculture, Santé, Industrie, Commerce international
|
REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS as NOVEL FOODS or INDUSTRIAL BIO_PRODUCTS in respect of an efficient science-based approach and allows for greater cooperation among and between government departments
|
Politique ou Programme, Règlement
|
|
Agriculture, Budget, Développement économique, Environnement, Santé, Industrie, Recherche et développement, Sciences et technologies
|
RESEARCH & DEVELOPMENT (R&D) to ensure Canadian capacity in key sectors including biomanufacturing, life sciences, and biotechnology.
|
Politique ou Programme
|
|
Santé
|
SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW to ensure Canada remains competitive overall and any new costs do not put bioloigics are a comparative disadvantage
|
Politique ou Programme
|
|
Santé, Industrie, Commerce international, Recherche et développement
|
VACCINE CONTRACTING AND SUPPLY to support the implementation of the federal biomanufacturing strategy, regulation of vaccines for Canadians, address immunization gaps, provide updated and timely information about vaccine development pipeline, support procurement of vaccines
|
Politique ou Programme
|
|
Santé, Industrie, Commerce international, Recherche et développement
|
Vaccine Funding - National Immunization Strategy - maintain federal leadership in providing provinces with funding for new vaccines
|
Politique ou Programme
|
BIOTECANADA IS A NOT-FOR-PROFIT ORGANIZATION THAT IS THE VOICE FOR BIOTECHNOLOGY IN CANADA. BIOTECANADA IS DEDICATED TO THE SUSTAINABLE COMMERCIAL DEVELOPMENT OF BIOTECHNOLOGY IN CANADA. IT FOCUSES ON THE ISSUES AND ACTIVITIES AFFECTING THE CANADIAN BIOTECHNOLOGY COMMUNITY, BOTH NATIONALLY AND INTERNATIONALLY. BIOTECANADA IS INVOLVED IN MANY INITIATIVES TO ADDRESS THESE ISSUES, INCLUDING REGULATORY AND POLICY ADVOCACY, FINANCE, AND THE COLLECTION AND DISSEMINATION OF MARKET INFORMATION. BIOTECANADA, IN PARTNERSHIP WITH THE REGIONAL BIOTECHNOLOGY ASSOCIATIONS, REPRESENTS 90 PERCENT OF THE CANADIAN BIOTECHNOLOGY COMMUNITY
ANDREW CASEY, President & CEO
Adresse :
410-410 Laurier Ave. W
OTTAWA, ON K1R 1B7
Canada
Numéro de téléphone :
613-230-5585
Poste
229